Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with multiple sclerosis (MS).
- People whose MS is the progressive type.
- People who are willing to take part voluntarily.
- People who are between 18 and 60 years old.
- People who are able to cooperate with the study requirements.
- People whose level of disability, as measured by a standard MS scale called the EDSS, is rated at 5.5 or higher, meaning MS has a significant impact on mobility (confirm with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have another condition affecting the brain or nervous system, in addition to MS.
- People whose MS medications have been changed in the last 3 months.
- People who have had an MS relapse (a flare-up of symptoms) in the last 3 months.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +903623121919
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Expanded Disability Status Scale (EDSS); Standardized Mini-Mental Test; Symbol Digit Modalities Test; Multiple Sclerosis Impact Scale (MSIS-29); Glial Fibrillary Acidic Protein (GFAP); Neurofilament Light Chain (NfL); Vascular Endothelial Growth Factor (VEGF)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.